Current Value
$298.231 Year Return
Current Value
$298.231 Year Return
Yahoo
In the latest trading session, Amgen (AMGN) closed at $295.18, marking a -1.73% move from the previous day.
Yahoo
Psoriatic arthritis is a chronic inflammatory disease linked to psoriasis, characterized by joint inflammation, pain, and swelling. Affecting both men and women, typically between ages 30-50, it's driven by rising autoimmune diseases and emerging biologic treatments like TNF and JAK inhibitors. Key market developments include advances in early diagnosis tools and precision medicine, tailoring treatments to genetic profiles. While growth is challenged by high biologic costs and diagnosis complexi
Yahoo
The Dow Jones Industrial Average gained ground as metal, cyclical and financial stocks kept a bullish profile. But data-center and security software stocks got stung.
SeekingAlpha
Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will solidify its market dominance for the next 5-7 years. Read more.
SeekingAlpha
Ultragenyx: 'Hold' The Best Strategy As Stock Tanks On Bone Disease Study Miss
Yahoo
From Amgen's classic double-bottom base in February 1990 until it ultimately topped in the summer of 2000, it increased more than 50 times.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -28.83% | $184.73M | 0.85% |
TAIL | -24.87% | $94.86M | 0.59% |
CLIP | -19.60% | $1.55B | 0.07% |
ULST | -15.28% | $592.38M | 0.2% |
IVOL | -11.59% | $342.69M | 1.02% |
CANE | -11.27% | $11.14M | 0.29% |
TFLO | -11.00% | $6.74B | 0.15% |
TPMN | -7.98% | $31.06M | 0.65% |
XHLF | -7.39% | $1.73B | 0.03% |
BTAL | -5.45% | $315.93M | 1.43% |
FTSD | -4.94% | $233.11M | 0.25% |
USDU | -4.50% | $129.80M | 0.5% |
FMF | -4.43% | $163.23M | 0.95% |
CTA | -3.81% | $1.08B | 0.76% |
TBLL | -3.73% | $2.12B | 0.08% |
BIL | -2.93% | $41.93B | 0.1356% |
UUP | -2.47% | $196.45M | 0.77% |
BOXX | -2.45% | $6.93B | 0.19% |
IBTF | -1.97% | $1.98B | 0.07% |
GBIL | -1.27% | $6.36B | 0.12% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XONE | 0.12% | $628.85M | 0.03% |
DBA | -0.19% | $768.97M | 0.93% |
KCCA | -0.38% | $108.37M | 0.87% |
SHYM | -0.39% | $355.86M | 0.35% |
URNM | 0.99% | $1.64B | 0.75% |
FXE | -1.04% | $588.06M | 0.4% |
URNJ | 1.05% | $291.41M | 0.8% |
USFR | 1.08% | $18.61B | 0.15% |
GBIL | -1.27% | $6.36B | 0.12% |
IBDQ | 1.63% | $2.96B | 0.1% |
WEAT | 1.72% | $123.28M | 0.28% |
USL | 1.76% | $43.93M | 0.85% |
UGA | 1.95% | $76.33M | 0.97% |
IBTF | -1.97% | $1.98B | 0.07% |
FXY | 2.04% | $802.69M | 0.4% |
SPTS | 2.28% | $5.77B | 0.03% |
SHV | 2.29% | $20.59B | 0.15% |
AGZD | 2.43% | $98.56M | 0.23% |
BOXX | -2.45% | $6.93B | 0.19% |
UUP | -2.47% | $196.45M | 0.77% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BVN | -0.05% | $4.19B | -4.73% | 0.00% |
LEU | -0.06% | $3.36B | +328.05% | 0.00% |
RLMD | 0.06% | $22.24M | -84.63% | 0.00% |
CPSH | -0.08% | $36.02M | +47.62% | 0.00% |
GALT | 0.09% | $155.06M | +3.81% | 0.00% |
AGX | -0.14% | $2.84B | +188.53% | 0.69% |
LITB | -0.15% | $24.26M | -71.62% | 0.00% |
LFWD | 0.18% | $11.71M | -80.85% | 0.00% |
NXE | -0.20% | $3.71B | -13.55% | 0.00% |
SHOP | -0.29% | $149.41B | +76.33% | 0.00% |
UEC | 0.36% | $2.79B | -5.29% | 0.00% |
QBTS | 0.45% | $5.00B | +1,256.78% | 0.00% |
VST | -0.48% | $66.43B | +113.71% | 0.46% |
BE | 0.57% | $6.00B | +93.34% | 0.00% |
K | -0.58% | $27.64B | +40.17% | 2.86% |
TH | -0.58% | $805.85M | -9.18% | 0.00% |
AXON | -0.66% | $57.06B | +151.75% | 0.00% |
SCKT | 0.67% | $9.82M | +10.68% | 0.00% |
ZVIA | -0.79% | $183.00M | +237.80% | 0.00% |
WRAP | 0.84% | $75.87M | -15.25% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BTCT | -19.75% | $28.19M | +79.43% | 0.00% |
MNOV | -13.42% | $62.29M | -8.63% | 0.00% |
HUSA | -10.04% | $20.99M | -8.33% | 0.00% |
TLN | -8.40% | $12.18B | +104.46% | 0.00% |
SPTN | -8.18% | $898.70M | +41.30% | 3.29% |
MVO | -7.22% | $69.00M | -38.46% | 20.74% |
DFDV | -5.97% | $363.21M | +2,422.23% | 0.00% |
LRN | -5.71% | $5.92B | +101.30% | 0.00% |
AIFU | -5.62% | $17.40M | +87.81% | 0.00% |
ALAR | -4.71% | $88.41M | -63.26% | 0.00% |
STG | -4.62% | $38.79M | -3.01% | 0.00% |
CEG | -4.26% | $98.29B | +44.63% | 0.48% |
QNRX | -4.11% | $5.30M | -60.39% | 0.00% |
RLX | -3.48% | $2.06B | +24.86% | 0.44% |
SYPR | -3.10% | $48.49M | +14.05% | 0.00% |
HTZ | -3.00% | $2.47B | +106.48% | 0.00% |
CCJ | -2.86% | $30.83B | +31.83% | 0.16% |
CLLS | -2.83% | $118.95M | -17.50% | 0.00% |
VHC | -2.64% | $69.05M | +176.10% | 0.00% |
FTNT | -2.13% | $76.69B | +70.44% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BBH | 72.83% | $339.54M | 0.35% |
FHLC | 68.42% | $2.43B | 0.084% |
XLV | 67.94% | $34.17B | 0.09% |
IYH | 67.87% | $2.72B | 0.39% |
VHT | 67.73% | $15.34B | 0.09% |
IXJ | 67.34% | $3.75B | 0.41% |
RSPH | 65.59% | $721.17M | 0.4% |
IBB | 64.65% | $5.37B | 0.45% |
PPH | 63.48% | $584.35M | 0.36% |
FXH | 61.88% | $891.22M | 0.62% |
FBT | 60.93% | $1.02B | 0.54% |
IHE | 60.75% | $551.02M | 0.39% |
PBE | 60.41% | $226.91M | 0.58% |
SCHD | 59.47% | $71.19B | 0.06% |
FDL | 56.74% | $5.60B | 0.43% |
XPH | 56.24% | $150.58M | 0.35% |
HDV | 56.16% | $11.21B | 0.08% |
FVD | 55.61% | $9.06B | 0.61% |
NOBL | 55.26% | $11.49B | 0.35% |
DHS | 55.23% | $1.25B | 0.38% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PFE | 58.14% | $146.57B | -10.05% | 6.62% |
BIIB | 56.48% | $19.83B | -42.85% | 0.00% |
IQV | 55.39% | $28.64B | -24.57% | 0.00% |
TECH | 55.08% | $8.53B | -28.75% | 0.60% |
TMO | 54.61% | $162.60B | -20.63% | 0.38% |
GSK | 51.87% | $80.01B | +1.75% | 4.17% |
ZTS | 51.48% | $70.70B | -10.66% | 1.18% |
RVTY | 50.66% | $12.07B | -6.76% | 0.28% |
ABBV | 50.59% | $344.45B | +14.77% | 3.30% |
MTD | 49.49% | $25.69B | -8.98% | 0.00% |
QGEN | 48.85% | $10.51B | +14.82% | 0.52% |
DHR | 48.28% | $147.08B | -16.55% | 0.57% |
NVS | 48.23% | $234.79B | +11.97% | 3.25% |
KHC | 48.05% | $31.33B | -17.74% | 6.12% |
LH | 47.90% | $21.22B | +22.97% | 1.14% |
LIN | 47.70% | $221.40B | +8.15% | 1.24% |
GILD | 47.65% | $142.48B | +63.70% | 2.75% |
PEP | 47.47% | $186.58B | -17.00% | 4.07% |
MEDP | 46.74% | $9.43B | -24.54% | 0.00% |
A | 46.64% | $35.27B | -5.08% | 0.80% |
Double maintains 15 strategies that include AMGN - Amgen, Inc.